please help me

Amy Dyken, controller at Carla Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Carla's financial statements. Below is selected financial information for the fiscal year ended June 30, 2020 . The following transactions have also occurred at Carla. 1. Options were granted on July 1. 2019, to purchase 220,000 shares at $15 per share. Although no options were exereised during fiscal year 2020 , the average price per common share during fiscal year 2020 was $20 per shares. 2. Each bond was issued at face value. The 7% convertible bonds will convert into common stock at 50 shares per $1,000 bond. The bonds are exercisable after 5 years and were issued in ficeal year 2019 . 3. The preferredstocic was issued in 2019 . 4. There are no preferred dividends in arrears; however, preferred dividends were not declared in fiscal year 2020. 5. The 990.000 shares of common stock were outstanding for the entire 2020 fiscal year. 6. Net income for fiscal year 2020 was $1,480,000, and the average income tax rate is 20%. For the fiscal year ended June 30,2020, calculate the following for Carla Pharmaceutical Industries, (Round answers to 2 decimal ploces, eg. \$2.45.) (a) Basic earnings per share. Basic earnings per share (b) Diluted earnings per share. Diluted earnings per share $5